PROTAGENIC THERAPEUTICS INC PTIX
COM NEW · Common Stock · CUSIP 74365N202
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNew York, NY
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.91.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2023 | 10 |
| Q2 2023 | 11 |
| Q3 2023 | 10 |
| Q4 2023 | 11 |
| Q1 2024 | 12 |
| Q2 2024 | 12 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2023 | 4 | 2 |
| Q3 2023 | 3 | 1 |
| Q4 2023 | 5 | 0 |
| Q1 2024 | 4 | 3 |
| Q2 2024 | 5 | 3 |
Biggest buyers
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | +26.6k |
| UBS Group AG | New | +10.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +4.0k |
| Tower Research Capital LLC (TRC) | Added | +993 |
| BANK OF AMERICA CORP /DE/ | Added | +28 |
Biggest sellers
| EAGLE ASSET MANAGEMENT INC | Sold out | -419.3k |
| WELLS FARGO & COMPANY/MN | Sold out | -27 |
| MORGAN STANLEY | Reduced | -2 |
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 1 | $6.5k | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| VANGUARD GROUP INC 0.00% of their portfolio | 33.2k $30.0k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 29.1k $26.8k | Added +4.0k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 26.6k $24.4k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 21.4k $19.5k | Unchanged |
| FNY Investment Advisers, LLC 0.01% of their portfolio | 18.8k $17.0k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 13.8k $12.7k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 10.1k $9.1k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 6.8k $6.2k | Added +993 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 29 $26 | Added +28 |
| MORGAN STANLEY 0.00% of their portfolio | 1 $1 | Reduced -2 |
| CWM, LLC 0.00% of their portfolio | 1 $0 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |